FBDD for SARS-CoV-2

With the SARS-CoV-2 (novel coronavirus, formerly known as 2019-nCoV) spreads around the world, scientists are speeding up the search for drugs that can treat COVID-19, a disease caused by the virus. Fragment-based drug discovery (FBDD) is a powerful tool for finding drug cues and plays an important role in the efficient development of specific and broad-spectrum antiviral agents. Creative Biostructure is a leading contract service provider for structure-based drug design (SBDD), and we currently provide FBDD services for the development of antiviral agents against coronavirus infection.